Department of Public Health Sciences, University of Virginia Health System, Charlottesville, VA.
Department of Health Services, School of Public Health, University of Washington, Seattle, WA.
Ann Surg. 2018 Oct;268(4):632-639. doi: 10.1097/SLA.0000000000002955.
To evaluate whether an association exists between the intensity of surveillance following surgical resection for non-small cell lung cancer (NSCLC) and survival.
Surveillance guidelines following surgical resection of NSCLC vary widely and are based on expert opinion and limited evidence.
A Special Study of the National Cancer Database randomly selected stage I to III NSCLC patients for data reabstraction. For patients diagnosed between 2006 and 2007 and followed for 5 years through 2012, registrars documented all postsurgical imaging with indication (routine surveillance, new symptoms), recurrence, new primary cancers, and survival, with 5-year follow-up. Patients were placed into surveillance groups according to existing guidelines (3-month, 6-month, annual). Overall survival and survival after recurrence were analyzed using Cox Proportional Hazards Models.
A total of 4463 patients were surveilled with computed tomography scans; these patients were grouped based on time from surgery to first surveillance. Groups were similar with respect to age, sex, comorbidities, surgical procedure, and histology. Higher-stage patients received more surveillance. More frequent surveillance was not associated with longer risk-adjusted overall survival [hazard ratio for 6-month: 1.16 (0.99, 1.36) and annual: 1.06 (0.86-1.31) vs 3-month; P value 0.14]. More frequent imaging was also not associated with postrecurrence survival [hazard ratio: 1.02/month since imaging (0.99-1.04); P value 0.43].
These nationally representative data provide evidence that more frequent postsurgical surveillance is not associated with improved survival. As the number of lung cancer survivors increases over the next decade, surveillance is an increasingly important major health care concern and expenditure.
评估非小细胞肺癌(NSCLC)手术后监测强度与生存之间是否存在关联。
NSCLC 手术后的监测指南差异很大,并且基于专家意见和有限的证据。
国家癌症数据库的一项特殊研究随机选择了 I 期至 III 期 NSCLC 患者进行数据重新提取。对于 2006 年至 2007 年间诊断并通过 2012 年随访 5 年的患者,记录员记录了所有术后影像学检查的指征(常规监测、新症状)、复发、新原发性癌症和生存情况,随访 5 年。根据现有指南(3 个月、6 个月、每年)将患者分为监测组。使用 Cox 比例风险模型分析总生存和复发后的生存。
共有 4463 例患者接受了计算机断层扫描监测;这些患者根据手术后首次监测的时间分组。各组在年龄、性别、合并症、手术程序和组织学方面相似。较高分期的患者接受了更多的监测。更频繁的监测与风险调整后的总生存时间无关[6 个月时的风险比为 1.16(0.99,1.36),每年时为 1.06(0.86-1.31)与 3 个月时;P 值为 0.14]。更频繁的影像学检查也与复发后生存无关[自影像学检查以来的风险比为 1.02/月(0.99-1.04);P 值为 0.43]。
这些具有全国代表性的数据提供了证据,表明更频繁的术后监测与改善生存无关。随着未来十年肺癌幸存者人数的增加,监测将成为一个越来越重要的主要医疗保健问题和支出。